Organovo
ONVO
#10473
Rank
ยฃ2.71 M
Marketcap
ยฃ1.51
Share price
1.49%
Change (1 day)
456.40%
Change (1 year)

P/E ratio for Organovo (ONVO)

P/E ratio as of December 2025 (TTM): -0.1771

According to Organovo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.177083. At the end of 2024 the company had a P/E ratio of -2.92.

P/E ratio history for Organovo from 2021 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2024-2.92179.27%
2023-1.05-57.59%
2022-2.4753.09%
2021-1.61

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Intuitive Surgical
ISRG
75.1-42,496.33%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
17.9-10,210.46%๐Ÿ‡บ๐Ÿ‡ธ USA
3D Systems
DDD
15.1-8,617.64%๐Ÿ‡บ๐Ÿ‡ธ USA
3M
MMM
25.4-14,455.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Stratasys
SSYS
-5.64 3,086.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
General Electric
GE
41.7-23,669.06%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.